Reaction
Intensive Care Unit Acquired Weakness reporting signals
As of the last recalculation, Intensive Care Unit Acquired Weakness appears in 377 FAERS reports alongside 27 co-occurring drug terms. The strongest observed disproportionality signal is MIDAZOLAM HYDROCHLORIDE (PRR 149.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Midazolam Hydrochloride | 61 | 149.0 | 149.4 |
| Propofol | 78 | 148.4 | 148.7 |
| Midazolam | 54 | 137.9 | 138.2 |
| Epoetin Alfa | 24 | 119.4 | 119.6 |
| Phenobarbital | 27 | 110.7 | 110.9 |
| Phenytoin | 36 | 105.2 | 105.4 |
| Amiodarone Hydrochloride | 17 | 87.7 | 87.8 |
| Rocuronium Bromide | 16 | 78.2 | 78.4 |
| Valproate Sodium | 27 | 77.6 | 77.7 |
| Diphenhydramine Hydrochloride Capsule, Liquid Filled | 24 | 66.2 | 66.2 |
| Rosuvastatin Calcium | 28 | 59.2 | 59.3 |
| Piperacillin And Tazobactam | 13 | 58.1 | 58.1 |
| Piperacillin Sodium,Tazobactam Sodium | 25 | 55.7 | 55.7 |
| Clobazam | 23 | 55.3 | 55.4 |
| Lacosamide | 29 | 46.5 | 46.6 |
| Levetiracetam In Sodium Chloride | 54 | 44.7 | 44.8 |
| Levetiracetam Oral | 54 | 44.7 | 44.8 |
| Levetiracetam Injection | 54 | 44.7 | 44.8 |
| Ceftriaxone | 24 | 43.1 | 43.1 |
| Fentanyl | 60 | 39.8 | 39.8 |
| Ceftriaxone Sodium | 25 | 38.5 | 38.5 |
| Vancomycin Hydrochloride | 40 | 37.4 | 37.4 |
| Tiotropium Bromide Inhalation Spray | 7 | 35.1 | 35.1 |
| Sitagliptin | 39 | 33.2 | 33.2 |
| Abiraterone | 6 | 24.7 | 24.7 |
| Lumacaftor And Ivacaftor | 3 | 19.5 | 19.5 |
| Remdesivir | 4 | 16.7 | 16.7 |